Fortrea HoldingsFTRE
FTRE
About: Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Employees: 15,000
0
Funds holding %
of 7,275 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
100% more call options, than puts
Call options by funds: $6.12M | Put options by funds: $3.05M
22% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 60
2% more funds holding
Funds holding: 345 [Q4 2024] → 352 (+7) [Q1 2025]
1% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 103
2.06% less ownership
Funds ownership: 106.35% [Q4 2024] → 104.29% (-2.06%) [Q1 2025]
60% less capital invested
Capital invested by funds: $1.78B [Q4 2024] → $710M (-$1.07B) [Q1 2025]
100% less funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 0 (-1) [Q1 2025]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$5
16%
upside
Avg. target
$8.25
92%
upside
High target
$15
249%
upside
4 analyst ratings
0 positive
0%
3 neutral
75%
1 negative
25%
Goldman Sachs Matthew Sykes | 16%upside $5 | Neutral Maintained | 14 May 2025 |
Mizuho Ann Hynes | 86%upside $8 | Neutral Maintained | 14 May 2025 |
Barclays Luke Sergott | 16%upside $5 | Underweight Maintained | 13 May 2025 |
Evercore ISI Group Elizabeth Anderson | 249%upside $15 | In-Line Maintained | 4 Mar 2025 |
Financial journalist opinion
Based on 8 articles about FTRE published over the past 30 days
Neutral
Business Wire
2 weeks ago
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On March 3, 2025, Fortrea rele.
Neutral
Business Wire
2 weeks ago
Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FORTREA HOLDINGS INC. (FTRE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights.
Neutral
Business Wire
2 weeks ago
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 3, 2025, Fortrea released its fourth quarter and fu.
Neutral
Seeking Alpha
2 weeks ago
Fortrea Holdings Inc. (FTRE) Q1 2025 Earnings Call Transcript
Fortrea Holdings Inc. (NASDAQ:FTRE ) Q1 2025 Earnings Conference Call May 12, 2025 9:00 AM ET Company Participants Hima Inguva - Head, Investor Relations and Corporate Development Tom Pike - Chief Executive Officer Jill McConnell - Chief Financial Officer Peter Neupert - Chairman and Interim CEO Conference Call Participants David Windley - Jefferies Justin Bowers - DB Patrick Donnelly - Citi Eric Coldwell - Baird Elizabeth Anderson - Evercore Charles Rhyee - TD Cowen Luke Sergott - Barclays Matt Sykes - Goldman Sachs Max Smock - William Blair Michael Ryskin - Bank of America Operator Ladies and gentlemen, thank you for standing by. And welcome to Fortrea First Quarter 2025 Earnings Conference Call.
Positive
Zacks Investment Research
2 weeks ago
Fortrea Holdings Inc. (FTRE) Q1 Earnings and Revenues Beat Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.04 per share a year ago.
Neutral
GlobeNewsWire
2 weeks ago
Fortrea Reports First Quarter 2025 Results
For the three months ended March 31, 2025, from continuing operations: Revenues of $651.3 million GAAP net loss of $(562.9) million, inclusive of a non-cash goodwill impairment charge Adjusted EBITDA of $30.3 million GAAP and adjusted net (loss) income per diluted share of $(6.25) and $0.02, respectively Book-to-bill ratio of 1.02x, resulting in 1.14x book-to-bill for the trailing 12 months DURHAM, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today reported financial results for the first quarter ended March 31, 2025.
Neutral
GlobeNewsWire
2 weeks ago
Fortrea Announces CEO Stepping Down
Peter M. Neupert, Fortrea's Lead Independent Director, will serve as Interim CEO as Thomas Pike steps down Peter M. Neupert, Fortrea's Lead Independent Director, will serve as Interim CEO as Thomas Pike steps down
Negative
Zacks Investment Research
3 weeks ago
Analysts Estimate Fortrea Holdings Inc. (FTRE) to Report a Decline in Earnings: What to Look Out for
Fortrea Holdings Inc. (FTRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
GlobeNewsWire
1 month ago
Fortrea Named a Leader in Everest Group's Pharmacovigilance Operations PEAK Matrix® Assessment 2025
DURHAM, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced it has been recognized as a “Leader” for pharmacovigilance (PV) operations by Everest Group in its annual Pharmacovigilance Operations PEAK Matrix® Assessment 2025.
Neutral
GlobeNewsWire
1 month ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Charts implemented using Lightweight Charts™